30
NAME OF DRUG ACTION INDICATION SIDE EFFECT ADVERSE REACTION NURSING REPONSIBILITIES GENERIC NAME: Felodipine BRAND NAME: Plendil CLASSIFICATIO N: Cardio/ Antihypertens ives/ Calcium Antagonists DOSAGE: Adults PO . 5mg OD Action: >Felodipine is known as a calcium channel blocker. By blocking calcium, this medication relaxes and widens blood vessels so blood can flow more easily. Indication: >Treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Contraindication: >Pregnancy. Unstable angina, significant aortic stenosis, w/in 1 month of myocardial infarction. Hypersensitivity. Precaution : >Hypotension. Eldery. Impaired hepatic function. Withdraw if ischaemic pain occurs or existing pain Side effect: >Flushing >Headache >Palpitations >Dizziness >Fatigue. >Peripheral edema >Nausea >Vomiting Rarely: >Tachycardia >Palpitations >Syncope >Rash >Pruritus. Adverse Reaction: Cardiovascula r Palpitation >Advise patient that dose of medication may be adjusted to obtain max benefit. >Advise patient to take once daily regularly with food or on an empty stomach. Caution patient to swallow tablets whole and not to crush, chew, cut, or break. >Inform patient that drug controls, but does not cure, hypertension or angina and to continue taking as prescribed even when BP is not

Final Drug Study

Embed Size (px)

Citation preview

Page 1: Final Drug Study

NAME OF DRUG

ACTION INDICATIONSIDE EFFECT

ADVERSE REACTION

NURSING REPONSIBILITIES

GENERIC NAME:Felodipine

BRAND NAME:Plendil

CLASSIFICATION:Cardio/ Antihypertensives/ Calcium Antagonists

DOSAGE:Adults

PO . 5mg OD

Action:>Felodipine is known as a calcium channel blocker. By blocking calcium, this medication relaxes and widens blood vessels so blood can flow more easily.

Indication:>Treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems.

Contraindication:>Pregnancy. Unstable angina, significant aortic stenosis, w/in 1 month of myocardial infarction. Hypersensitivity.

Precaution :>Hypotension. Eldery. Impaired hepatic function. Withdraw if ischaemic pain occurs or existing pain worsens shortly after initiating treatment or if cardiogenic shock develops. Grapefruit juice should be avoided since it may cause an increase in felodipine plasma concentrations.

Side effect:>Flushing>Headache>Palpitations>Dizziness>Fatigue. >Peripheral edema >Nausea >Vomiting

Rarely:>Tachycardia >Palpitations >Syncope >Rash>Pruritus.

Adverse Reaction:

Cardiovascular

Palpitation (at least 1.5%).

CNS

Asthenia, dizziness, headache, paresthesia (at least

>Advise patient that dose of medication may be adjusted to obtain max benefit. >Advise patient to take once daily regularly with food or on an empty stomach. Caution patient to swallow tablets whole and not to crush, chew, cut, or break. >Inform patient that drug controls, but does not cure, hypertension or angina and to continue taking as prescribed even when BP is not elevated or angina symptoms are not present. >Caution patient not to change or stop taking the dose unless advised by health care provider. >Instruct patient to continue taking other BP medications as prescribed by health care provider. >Instruct patient who also has angina to notify health care provider if frequency

Page 2: Final Drug Study

1.5%).

Dermatologic

Flushing, rash (at least 1.5%).

EENT

Rhinorrhea, sneezing (at least 1.5%).

GI

Constipation, dyspepsia, nausea (at least 1.5%).

Respiratory

Cough, upper respiratory infection (at least 1.5%).

Miscellaneous

Peripheral edema, warm sensation (at least 1.5%).

or severity of chest pain, or need for sublingual nitroglycerin appears to be increasing. >Instruct patient in BP and pulse measurement skills. >Advise hypertensive patient to monitor and record BP and pulse at home and to inform health care provider if abnormal measurements are noted. >Also advise patient to take record of BP and pulse to each follow-up visit. >Instruct patient to lie or sit down if experiencing dizziness or lightheadedness while standing. >Advise patient to notify health care provider if any of the following occur: frequent episodes of dizziness when arising, swelling of lower legs or ankles, persistent fatigue, any other unusual or unexplained symptoms or signs. >Advise patient that medication can cause gum

Page 3: Final Drug Study

GENERIC Action: Indication:

swelling but that good dental hygiene reduces the risk and severity. >Emphasize to hypertensive patient the importance of other modalities on BP: weight control, regular exercise, smoking cessation, and moderate intake of alcohol and salt.

NURSING

Page 4: Final Drug Study

NAME:Allopurinol

BRAND NAME:Llanol

CLASSIFICATION:Gout PreparationsAnalgesicsUricosurics

DOSAGE: PO 100mg 1 tabBID

>Reduces uric acid production by inhibiting biochemical reactions preceding its formation.

>Prevention of attack of gouty arthritis and nephropathy. >Treatment of secondary hyperuricemia which may occur during treatment of tumors or leukemia.>Prevention of recurrent calcium oxalate calculi

Special precaution:>Discontinue immediately at the first appearance of rash or any sign that may indicate an allergic reaction. Severe hypersensitivity reactions such as exfoliative, urticarial and purpuric lesions as well as Stevens-Johnson syndrome and/or generalized vasculitis have been reported following appearance of rash. Patients under treatment for hypertension or cardiac insufficiency, such as with diuretics or ACE inhibitors; reversible clinical hepatotoxicity.

Contraindication:Hypersensitivity toDrug.

Side Effect:> Gastrointestinal disturbances>skin reactions (e.g., pruritic maculopapular rash)> alterations in liver function test results.

Adverse Reaction:

>Dermatologic: Rash

>Endocrine & metabolic: Gout (acute)

>Gastrointestinal: Diarrhea, nausea

>Hepatic: Alkaline phosphatase increased, liver enzymes increased

REPONSIBILITIES:

>monitor serum uric acid levels to evaluate drug’s effectiveness

>monitor fluid intake and output; daily urine output of at least 2 liters and maintenance of neutral or slightly alkaline urine are desirable

>periodically monitor CBC and hepatic and renal function, especially at start of therapy, as ordered

>If renal insufficiency occurs at any time during treatment, be prepared to reduce dosage, as ordered.

>Optimal benefits may require 2-6 weeks of therapy. Because acute gouty attacks occur during this time, concurrent use of colchicines may be prescribed prophylactically.

>To minimize GI

Page 5: Final Drug Study

disturbance, tell patient to take with or immediately after meals.

>Encourage the patient to drink plenty of fluids while taking this drug unless otherwise contraindicated.

>Drug may cause drowsiness, tell patient not to drive or perform hazardous tasks requiring mental alertness until CNS effects of the drug are known.

>If the patient is taking allopurinol for treatment of recurrent calcium oxalate stones, advise him to also reduce his dietary intake of animal protein, sodium, refined sugars, oxalate-rich foods, and calcium.

>Tell patient to discontinue at first sign of rash, which may precede severe hypersensitivity or

Page 6: Final Drug Study

GENERIC Action: Indication:

other adverse reaction. Rash is more common in patient taking diuretics and in those with renal disorders. Tell the patient to report all adverse reactions.

Page 7: Final Drug Study

NAME:Trimetazidine

BRAND NAME:Vastarel MR

CLASSIFICATION:Anti-Anginal

DOSAGE:PO 35mg BID1 tab in morning and evening.

>Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism.

> By preserving the energy metabolism in cells exposed to hypoxia or ischemia, trimetazidine prevents a decrease in intracellular adenosine triphosphate levels, thereby ensuring the proper functioning of ionic pumps and transmembranous sodium-potassium flow whilst maintaining cellular homeostasis. It also inhibits oxidation of fatty acid in blood vessels.

> increases coronary flow reserve, thereby delaying the onset of ischemia associated with exercise, limits rapid swings in blood pressure

>Preventive treatment for angina pectoris episodes.

>Treatment of vertigo and tinnitus as well as visual disorders with a circulatory origin.

Precaution:>This drug is not a curative treatment for angina attacks, nor is it indicated as an initial treatment for unstable angina, or myocardial infarction. In the event of an angina attack, the coronaropathy should be reevaluated and an adaptation of the treatment considered (drug treatment and possibly revascularisation).

Contraindication:>Do not take Vastarel MR if you are allergic to any of the constituents.This drug is generally not recommended during breast feeding

Side Effect:>Nausea>vomiting >GI disorders>Fever >Rash>Respiratory illness >Anemia.

Nursing Responsibilities:>Assess location, duration and intensity of anginal pain>Monitor BP and PR before and after administering the drug>Notify prescribing signs of heart failure such as swelling of the hands and feet or shortness of breath>Instruct to avoid strenuous or hazardous activities requiring alertness to prevent risks of falls and injury> Tablets should be taken at mealtimes with a full glass of water.

Page 8: Final Drug Study

Generic Name:

without any significant variations in heart rate,

>significantly decreases the frequency of angina attacks, and leads to a significant decrease in the use of nitrates.

> It improves left ventricular function in diabetic patients with coronary heart disease.

Action: Indication:

Page 9: Final Drug Study

furosemide

Brand Name:Lasix

Classification:Electrolytic and water balance agent

Loop diuretic

Dose, Route,

IV 20g

Rapid-acting potent sulfonamide “loop” diuretic and antihypertensive with pharmacologic effects and uses almost identical to those of ethacrynic acid. Exact mode of action not clearly defined; decreases renal vascular resistance and may increase renal blood flow.

>Treatment of edema associated with CHF, cirrhosis of liver, and kidney disease, including nephrotic syndrome. May be used for management of hypertension, alone or in combination with other antihypertensive agents, and for treatment of hypercalcemia. Has been used concomitantly with mannitol for treatment of severe cerebral edema, particularly in meningitis.

CONTRAINDICATIONS

>History of hypersensitivity to furosemide or sulfonamides; increasing oliguria, anuria, fluid and electrolyte depletion states; hepatic coma; pregnancy (category C), lactation.

Side Effect:>Low blood pressure, >Dehydration and electrolyte depletion.

Adverse Reaction:>CV: Postural hypotension, dizziness with excessive diuresis, acute hypotensive episodes, circulatory collapse.

>Metabolic: Hypovolemia, dehydration, hyponatremia hypokalemia, hypochloremia metabolic alkalosis, hypomagnesemia, hypocalcemia (tetany), hyperglycemia, glycosuria, elevated BUN, hyperuricemia.

NURSING RESPONSIBILITIES>Observe patients receiving parenteral drug carefully; closely monitor BP and vital signs. Sudden death from cardiac arrest has been reported.

>Monitor BP during periods of diuresis and through period of dosage adjustment.

>Observe older adults closely during period of brisk diuresis. Sudden alteration in fluid and electrolyte balance may precipitate significant adverse reactions. Report symptoms to physician.

>Lab tests: Obtain frequent blood count, serum and urine electrolytes, CO2, BUN, blood sugar, and uric acid values during first few months of therapy and periodically thereafter.

Page 10: Final Drug Study

>GI:Nausea, vomiting, oral and gastric burning, anorexia, diarrhea, constipation, abdominal cramping, acute pancreatitis, jaundice.

>Urogenital: Allergic interstitial nephritis, irreversible renal failure, urinary frequency.

>Hematologic: Anemia, leukopenia, thrombocytopenic purpura; aplastic anemia, agranulocytosis (rare).

Special Senses: Tinnitus, vertigo, feeling of fullness in ears, hearing loss (rarely permanent),

>Monitor for S&S of hypokalemia.

>Monitor I&O ratio and pattern. Report decrease or unusual increase in output. Excessive diuresis can result in dehydration and hypovolemia, circulatory collapse, and hypotension. Weigh patient daily under standard conditions.

>Monitor urine and blood glucose & HbA1C closely in diabetics and patients with decompensated hepatic cirrhosis. Drug may cause hyperglycemia.

>Note: Excessive dehydration is most likely to occur in older adults, those with chronic cardiac disease on prolonged salt restriction, or those receiving sympatholytic agents.

Patient & Family Education

Page 11: Final Drug Study

Generic Name: Action: Indication:

blurred vision. Skin: Pruritus, urticaria, exfoliative dermatitis, purpura, photosensitivity, porphyria cutanea tarde, necrotizing angiitis (vasculitis).

Body as a Whole: Increased perspiration; paresthesias; activation of SLE, muscle spasms, weakness; thrombophlebitis, pain at IM injection site.

>Consult physician regarding allowable salt and fluid intake.

>Ingest potassium-rich foods daily (e.g., bananas, oranges, peaches, dried dates) to reduce or prevent potassium depletion.

>Learn S&S of hypokalemia. Report muscle cramps or weakness to physician.

>Make position changes slowly because high doses of antihypertensive drugs taken concurrently may produce episodes of dizziness or imbalance.

>Avoid replacing fluid losses with large amounts of water.

>Avoid prolonged exposure to direct sun.

>Do not breast feed while taking this drug.

Page 12: Final Drug Study

Ketorolac

Brand Name:Toradol

Classification:Nonsteroidal anti-inflammatory agents, nonopioid analagesics

Dose, Route,IV 30mg q82 doses

>Inhibits prostaglandin synthesis, producing peripherally mediated analgesia.

>Also has antipyretic and anti-inflammatory properties.

>Therapeutic effect:Decreased pain

>Short term management of pain (not to exceed 5 days total for all routes combined)

Contraindication:>Hypersensitivity>Cross-sensitivity with other NSAIDs may exist¨Pre- or perioperative use>Known alcohol intolerance Use cautiously in:

1) History of GI bleeding2) Renal impair-ment (dosage reduction may be required)3) Cardiovascular disease.

Side Effect/ Anverse reactionCNS:1) drowsiness2) abnormal thinking3) dizziness4) euphoria5) headache

RESP:1) asthma2) dyspnea

CV:1) edema2) pallor3) vasodilation

GI:1) GI Bleeding2) abnormal taste3) diarrhea4) dry mouth5) dyspepsia6) GI pain7) nausea

GU:1) oliguria2) renal toxicity3) urinary frequency

Nursing Responsibilities:

>Patients who have asthma, aspirin-induced allergy, and nasal polyps are at increased risk for developing hypersensitivity reactions.

>Assess for rhinitis, asthma, and urticaria.

> Assess pain (note type, location, and intensity) prior to and 1-2 hr following administration.

> Ketorolac therapy should always be given initially by the IM or IV route. Oral therapy should be used only as a continuation of parenteral therapy.>Caution patient to avoid concurrent use of alcohol, aspirin, NSAIDs, acetaminophen, or other

Page 13: Final Drug Study

Generic Name: Action: Indication:

DERM:1) pruritis2) purpura3) sweating4) urticaria

HEMAT:1) prolonged bleeding time

> LOCAL:1) injection site pain- NEURO:1) paresthesia- MISC:1) allergic reaction, anaphylaxis

Side effect/ Adverse reaction

OTC medications without consulting health care professional.

>Advise patient to consult if rash, itching, visual disturbances, tinnitus, weight gain, edema, black stools, persistent headche, or influenza-like syndromes (chills,fever,muscles aches, pain) occur.

>Effectiveness of therapy can be demonstrated by decrease in severity of pain. Patients who do not respond to one NSAIDs may respond to another.

Page 14: Final Drug Study

Meropenem

Brand Name:Merrem

Classification:antiinfective; carbapenem antibiotic

Dose, Route,IV q12

>Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.

>Meropenem is bactericidal except against Listeria monocytogenes where it is bacteriostatic. It inhibits bacterial wall synthesis like other beta-lactam antibiotics.

>used in the treatment of infections of the abdomen, such as appendicitis and peritonitis, bacterial meningitis (infection of the lining of the brain), and skin infections.

>used to treat a wide variety of bacterial infections. This medication is known as a carbapenem-type antibiotic. It works by stopping the growth of bacteria.

Precaution:Before using meropenem, tell your doctor or pharmacist if you are allergic to it; or to penicillins or cephalosporins; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.Before using this medication, tell your doctor or pharmacist your medical history, especially of: brain disorders (e.g., seizures, head injury, tumor), kidney disease, stomach/intestinal diseases (e.g., colitis).Kidney function declines as you grow older. This medication is removed by the

>allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives)

>seizures

>severe or watery diarrhea;

>skin rash;

>unusual tiredness or weakness; or

>unusual bleeding or bruising.

Less serious side effect:

>nausea or vomiting;

>diarrhea or constipation

>headache

>soreness, redness,

Nursing Responsibilities:>Lab tests: Perform C&S tests prior to therapy. Monitor periodically liver and kidney function.

>Determine history of hypersensitivity reactions to other beta-lactams, cephalosporins, penicillins, or other drugs.

>Discontinue drug and immediately report S&S of hypersensitivity.

>Report S&S of superinfection or pseudomembranous colitis.

>Monitor for seizures especially in older adults and those with renal insufficiency.

Patient & Family Education

>Learn S&S of

Page 15: Final Drug Study

Generic Name: Action:

kidneys. Therefore, elderly people may be at greater risk for side effects while using this drug.Tell your doctor if you are pregnant before using this medication.It is not known whether this drug passes into breast milk. Consult your doctor before breast-feeding.

Indication:

or mild swelling at the injection site.

Side effect/ Adverse Reaction:

hypersensitivity, superinfection, and pseudomembranous colitis; report any of these to physician promptly.

>Do not breast feed while using this drug.

Page 16: Final Drug Study

CLONIDINE HYDROCHLORIDE

Brand Name:Catapres

Classification:cardiovascular agent; central-acting antihypertensive; analgesic

Dose, Route,PRN:q6If BP is > or = 150/100Sublingual

>Centrally acting antiadrenergic derivative. Stimulates alpha2-adrenergic receptors in CNS to inhibit sympathetic vasomotor centers. Central actions reduce plasma concentrations of norepinephrine. It decreases systolic and diastolic BP and heart rate. Orthostatic effects tend to be mild and occur infrequently. Also inhibits renin release from kidneys.

>Step 2 drug in stepped-care approach to treatment of hypertension, either alone or with diuretic or other antihypertensive agents. Epidural administration as adjunct therapy for severe pain.

Contraindication:>Pregnancy (category C), lactation. Use of clonidine patch in polyarteritis nodosa, scleroderma, SLE

CV: Hypotension (epidural), postural hypotension (mild), peripheral edema, ECG changes, tachycardia, bradycardia, flushing, rapid increase in BP with abrupt withdrawal. GI: Dry mouth, constipation, abdominal pain, pseudo-obstruction of large bowel, altered taste, nausea, vomiting, hepatitis, hyperbilirubinemia, weight gain (sodium retention).

CNS: Drowsiness, sedation, dizziness, headache, fatigue, weakness, sluggishness, dyspnea, vivid dreams, nightmares, insomnia, behavior changes, agitation,

Nursing Responsibilities:>Monitor BR closely. Determine positional changes (supine, sitting, standing).

>With epidural administration, frequently monitor BP and HR. Hypotension is a common side effect that may require intervention.

>Monitor BP closely whenever a drug is added to or withdrawn from therapeutic regimen.

>Monitor I&O during period of dosage adjustment. Report change in I&O ratio or change in voiding pattern.

>Determine weight daily. Patients not receiving a concomitant diuretic agent may gain weight, particularly during first 3

Page 17: Final Drug Study

Generic Name: Action: Indication:

hallucination, nervousness, restlessness, anxiety, mental depression. Skin: Rash, pruritus, thinning of hair, exacerbation of psoriasis; with transdermal patch: hyperpigmentation, recurrent herpes simplex, skin irritation, contact dermatitis, mild erythema. Special Senses: Dry eyes. Urogenital: Impotence, loss of libido.

Side effect:Nausea

or 4 d of therapy, because of marked sodium and water retention.

>Supervise closely patients with history of mental depression, as they may be subject to further depressive episodes.

Page 18: Final Drug Study

Tramadol

Brand Name:Dolcet

Classification:Analgesics/ Opiates & Antagonists

Dose, RoutePO 1 tabTID

>exhibits analgesic action by peripheral blockage of pain impulse generation. It produces antipyresis by inhibiting the hypothalamic heat-regulating centre. Its weak anti-inflammatory activity is related to inhibition of prostaglandin synthesis in the CNS.

used in treating moderate to severe pain. The drug has a wide range of applications, including treatment for restless leg syndrome and fibromyalgia.

Precaution:>Epilepsy, history of seizures, or recognized risk for seizure (such as head trauma, metabolic disorders, alcohol and drug withdrawal, CNS infection); history of anaphylactoid reactions to codeine and other opioids; patients at risk for respiratory depression; increased intracranial pressure or head injury; patients receiving CNS depressants; opioid-dependent patients; chronic heavy alcohol abusers; patients taking MAO inhibitors or SSRI; impaired renal function. May impair driving or operating machinery.

Contraindication:Hypersensitivity. Acute intoxication with alcohol, hypnotics, narcotics, centrally-acting analgesics, opioids or psychotropic drugs. Severe hepatic impairment; pregnancy, lactation.

Dizzinesssomnolence.

Adverse Reaction:CNS and GI disturbances. Nausea,DizzinessFatigueConstipationdry mouth.

Nursing Responsibilities:

>Assess for level of pain relief and administer prn dose as needed but not to exceed the recommended total daily dose.

>Monitor vital signs and assess for orthostatic hypotension or signs of CNS depression.

>Discontinue drug and notify physician if S&S of hypersensitivity occur.

>Assess bowel and bladder function; report urinary frequency or retention.

>Use seizure precautions for patients who have a history of seizures or who are concurrently using drugs that lower the

Page 19: Final Drug Study

GENERIC Action: Indication:Side effect:

seizure threshold.

>Monitor ambulation and take appropriate safety precautions.

Patient & Family Education

>Exercise caution with potentially hazardous activities until response to drug is known.

>Understand potential adverse effects and report problems with bowel and bladder function, CNS impairment, and any other bothersome adverse effects to physician.

>Do not breast feed while taking this drug.

Page 20: Final Drug Study

NAME:Etoricoxib

BRAND NAME:Arcoxia

CLASSIFICATION:non-steroidal anti-inflammatory drug (NSAID).

DOSAGE AND ROUTE:PO 60mg 1 tabBID

>NSAIDs work by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in producing prostaglandins, in response to injury or certain diseases. These prostaglandins cause pain, swelling and inflammation. Because NSAIDs block the production of these prostaglandins, they are effective at relieving pain and inflammation.

acute and chronic treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis

management of ankylosing spondylitis

relief of chronic musculoskeletal pain

relief of acute pain

to treat acute gouty arthritis

Contraindication:

you have an allergy to Arcoxia or any of the ingredients listed at the end of this leaflet

the packaging is torn or shows signs of tampering

the expiry date on the pack has passed.If you take this medicine after the expiry date has passed, it may not work.

feeling sick (nausea), vomiting

heartburn, indigestion, uncomfortable feeling or pain in the stomach

diarrhoea

swelling of the legs, ankles or feet

high blood pressure

dizziness

headache

Adverse Reaction:

swelling of the face, lips, tongue or throat which may cause difficulty in swallowing or breathing

Nursing Responsibilities:Allergic disorders

coagulation defects

history of cardiac failure

left ventricular dysfunction,

hypertension or in patientswith edema due to other reasons; elderly

renal,cardiac

hepatic impairment 

Page 21: Final Drug Study

You have had heart failure, a heart attack, bypass surgery, chest pain (angina), narrow or blocked arteries of the extremities (peripheral arterial disease), a stroke or mini stroke (TIA or transient ischaemic attack).

You have high blood pressure that is not well controlled on blood pressure medication.

You are having major surgery and have conditions which increase your risk of coronary artery disease or atherosclerosis such as high blood pressure, diabetes, high cholesterol or smoking.

You are having major surgery on you heart or arteries.

(hypersensitivity reactions, anaphylactic/anaphylactoid reactions including shock)

abnormal rhythm of the heart (atrial fibrillation)

heart failure

palpitations

serious kidney problems

serious liver problems

stomach pain

stomach ulcers that may become serious and may bleed, and may occur at any time during use and without warning.

Page 22: Final Drug Study